Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608

---
identifier: "/us/fr/E6-5361"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608"
title_number: 0
title_name: "Federal Register"
section_number: "E6-5361"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608"
positive_law: false
currency: "2006-04-12"
last_updated: "2006-04-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-5361"
document_type: "notice"
publication_date: "2006-04-12"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 18763"
fr_volume: 71
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

**Name:**

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608.

**Times and Dates:**

3 p.m.-5:40 p.m., May 3, 2006 (Closed) 9 a.m.-6 p.m., May 4, 2006 (Closed) 9 a.m.-12 p.m., May 5, 2006 (Closed)

**Place:**

Atlanta Marriott North Central, 2000 Century Boulevard NE., Atlanta, GA 30345 Telephone 404.325.0000.

**Status:**

The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

**Matters to Be Discussed:**

The meeting will include the review, discussion, and evaluation of applications received in response to Capacity-Building Assistance to Improve the Delivery and Effectiveness of Human Immunodeficiency Virus (HIV) Prevention Interventions for Individuals with Known HIV-Positive Serostatus and Their Partners, PS 06-608.

**For More Information Contact:**

Beth Wolfe, Designated Federal Official, Prevention Support Office, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road NE, MS E-07, Atlanta, GA 30333, Telephone 404.639.8531.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 5, 2006.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.